Carlos Garcia-Parada - Feb 14, 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: Chief Financial Officer
Signature: /s/ Martin Wilson, as attorney-in-fact for Carlos Garcia-Parada
Stock symbol: RCKT
Transactions as of: Feb 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/16/2022, 08:32 PM
Previous filing: Sep 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCKT	Stock Option (Right to Buy)	Award	$0	+54K		$0.00	54K	Feb 14, 2022	Common Stock	54K	$20.00	Direct	F1
transaction	RCKT	Restricted Stock Units	Award	$0	+17.3K		$0.00	17.3K	Feb 14, 2022	Common Stock	17.3K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option represents a right to purchase a total of 54,006 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.
F2	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3	One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Remarks:

Exhibit 24: Power of Attorney